Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
'An incredible privilege and responsibility': Artemis 2's Christina Koch is ready to become the 1st woman to fly around the moon - 2Alice Wong, founder of the Disability Visibility Project, dies at 51
- 3Releasing Learning Experiences: A Survey of the \Learning Made Fun\ Instructive Application
- 4Are your hormones imbalanced? Doctors explain how to know if you need testing
- 5FDA official discusses potential link between COVID-19 vaccines and pediatric deaths
- This Is Canada's Only Province Without Any Bears
- Former Peruvian President Pedro Castillo sentenced for conspiracy
- Most loved Caf\u00e9 Chain: Where Do You Get Your Caffeine Fix
- French rapper Gims placed under investigation for 'aggravated money laundering'
- Baby takes 1st steps after receiving groundbreaking gene-edited therapy
- Building an Individual Brand: Illustrations from Forces to be reckoned with
- From record warming to rusting rivers, 2025 Arctic Report Card shows a region transforming faster than expected
- Young Muslims in Germany feel left out of Mideast debate, experts say
- Mojtaba Khamenei unconscious in Qom, not actually running Iran
